| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a compound as an effective ingredient, that is a pyrazolone compound, as an improved effective ingredient that responds to demands in pharmaceutical markets and that is effective for the treatment of diseases relating to ischemic stroke. <P>SOLUTION: A drug for the treatment of cerebrovascular disorders associated with insufficient cerebral circulation such as ischemic stroke is provided, wherein the drug comprises a pharmaceutically effective amount of a pyrazolone compound expressed by structural formula (I) or a pharmaceutically acceptable salt thereof, or a pseudo-polymorphic form thereof, and wherein the drug is administered at a controlled dose in such a manner that the plasma concentration of unchanged form is kept constant for a predetermined period of time and that the compound exhibits a higher effect. <P>COPYRIGHT: (C)2012,JPO&INPIT |
